Found: 23
Select item for more details and to access through your institution.
Evaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver Tumor Burden.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 6, p. 880, doi. 10.2967/jnumed.122.264533
- By:
- Publication type:
- Article
Incidental Airway Findings on PET/CT with <sup>18</sup>F-PSMA.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 6, p. 993, doi. 10.2967/jnumed.122.265270
- By:
- Publication type:
- Article
Nuclear Receptor Imaging In Vivo—Clinical and Research Advances.
- Published in:
- Journal of the Endocrine Society, 2023, v. 7, n. 3, p. 1, doi. 10.1210/jendso/bvac197
- By:
- Publication type:
- Article
Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma.
- Published in:
- Journal of Blood Medicine, 2023, v. 14, p. 49, doi. 10.2147/JBM.S391094
- By:
- Publication type:
- Article
Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [ 68 Ga]Ga DOTATATE PET-CT.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6039, doi. 10.3390/cancers14246039
- By:
- Publication type:
- Article
Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes.
- Published in:
- Journal of Blood Medicine, 2022, v. 13, p. 663, doi. 10.2147/JBM.S384983
- By:
- Publication type:
- Article
A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4276, doi. 10.3390/cancers14174276
- By:
- Publication type:
- Article
<sup>177</sup>Lu-PSMA Therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1361, doi. 10.3390/cancers14061361
- By:
- Publication type:
- Article
Neuropsychiatric Manifestations of Lymphoma-Associated Cerebral Glucose Hypometabolism Can Be Reversed by Intensive Glucose Supplementation.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2022, v. 12, p. 17, doi. 10.2147/BLCTT.S353430
- By:
- Publication type:
- Article
<sup>82</sup>Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 66, n. 1, p. 74, doi. 10.23736/S1824-4785.19.03173-X
- By:
- Publication type:
- Article
Advances and Future Directions of Molecular Breast Imaging.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261988
- By:
- Publication type:
- Article
Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients.
- Published in:
- Annals of Nuclear Medicine, 2021, v. 35, n. 11, p. 1264, doi. 10.1007/s12149-021-01675-8
- By:
- Publication type:
- Article
Neuro-Oncology Practice Clinical Debate: FDG PET to differentiate glioblastoma recurrence from treatment-related changes.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 5, p. 518, doi. 10.1093/nop/npab027
- By:
- Publication type:
- Article
Letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients—a report of the PET/RANO group": <sup>18</sup>F-fluciclovine and target volume delineation.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 8, p. 1408, doi. 10.1093/neuonc/noab097
- By:
- Publication type:
- Article
[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00739-6
- By:
- Publication type:
- Article
Fifty Years of Radiopharmaceuticals.
- Published in:
- Journal of Nuclear Medicine Technology, 2020, v. 48, p. 34S
- By:
- Publication type:
- Article
[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 3, p. 579, doi. 10.1007/s00259-019-04614-y
- By:
- Publication type:
- Article
[<sup>18</sup>F]Fluciclovine PET discrimination between high- and low-grade gliomas.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0415-3
- By:
- Publication type:
- Article
Update on <sup>18</sup>F-Fluciclovine PET for Prostate Cancer Imaging.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 733, doi. 10.2967/jnumed.117.204032
- By:
- Publication type:
- Article
<sup>18</sup>F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors.
- Published in:
- Neuro-Oncology Practice, 2018, v. 5, n. 1, p. 28, doi. 10.1093/nop/npx008
- By:
- Publication type:
- Article
PET/MRI for the body imager: abdominal and pelvic oncologic applications.
- Published in:
- Abdominal Imaging, 2015, v. 40, n. 6, p. 1387, doi. 10.1007/s00261-015-0390-3
- By:
- Publication type:
- Article
7α-<sup>18</sup>FF-Fluoromethyl-Dihydrotestosterone and 7α-<sup>18</sup>F-Fluoromethyl-Nortestosterone: Ligands to Determine the Role of Sex Hormone--Binding Globulin for Steroidal Radiopharmaceuticals.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 6, p. 987, doi. 10.2967/jnumed.107.048926
- By:
- Publication type:
- Article